首页> 外文期刊>Cardiovascular Research >Barth syndrome cardiomyopathy
【24h】

Barth syndrome cardiomyopathy

机译:Barth综合征心肌病

获取原文
获取原文并翻译 | 示例
           

摘要

Barth syndrome (BTHS) is an inherited form of cardiomyopathy, caused by a mutation within the gene encoding the mitochondrial transacylase tafazzin. Tafazzin is involved in the biosynthesis of the unique phospholipid cardiolipin (CL), which is almost exclusively found in mitochondrial membranes. CL directly interacts with a number of essential protein complexes in the mitochondrial membranes including the respiratory chain, mitochondrial metabolite carriers, and proteins, involved in shaping mitochondrial morphology. Here we describe, how in BTHS CL deficiency causes changes in the morphology of mitochondria, structural changes in the respiratory chain, decreased respiration, and increased generation of reactive oxygen species. A large number of cellular and animal models for BTHS have been established to elucidate how mitochondrial dysfunction induces sarcomere disorganization and reduced contractility, resulting in dilated cardiomyopathy in vivo.
机译:Barth综合征(bths)是一种遗传形式的心肌病,由编码线粒体酸酯Tafazzin的基因内的突变引起。 Tafazzin参与了独特的磷脂心脂(CL)的生物合成,几乎完全在线粒体膜中发现。 CL直接在线粒体膜中与许多必需蛋白质复合物相互作用,包括呼吸链,线粒体代谢物载体和蛋白质,参与成型线粒体形态。 在这里,我们描述了,Cl Cl缺乏程度如何导致线粒体形态的变化,呼吸链的结构变化,降低呼吸和增加的反应性氧。 已经建立了大量的BTH细胞和动物模型,以阐明线粒体功能障碍如何诱导肉瘤紊乱和减少的收缩性,导致体内扩张的心肌病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号